The U.S. Food and Drug Administration (FDA) last month approved a rechargeable neurostimulator and a recharge-free neurostimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN). Medtronic is marketing the products as Intellis™ and Vanta™, respectively. DPN is a debilitating and progressive neurological disorder that affects approximately 30% of people with diabetes,...
Obesity Is More Prevalent in People with Type 1 Diabetes than Previously Thought
People with type 1 diabetes should be screened regularly for obesity and chronic kidney disease, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Almost half of the adults in the U.S. have obesity, a chronic progressive disease characterized by an individual having an excess of body fat. Obesity is one of...
Abbott, ADA Launch Community Initiative to Advance Access to Diabetes Care and Technology
Last November, Abbott and the American Diabetes Association (ADA) announced the launch of their first joint community health partnership. The community initiative, which is the first program under the ADA’s Health Equity Now platform, will launch in Columbus, Ohio, and be conducted in partnership with the National Center for Urban Solutions (NCUS), a Columbus-based organization...
High Altitude Exercise Could Increase Hypoglycemia Risk in People with Diabetes
People with diabetes may need to monitor their blood sugar more closely when doing high-altitude activities such as hiking or skiing, according to a small study published in the Society’s Journal of Clinical Endocrinology & Metabolism. Doctors often recommend exercise for people with diabetes as it has many benefits. It can improve heart health, insulin sensitivity, and quality of life. However, exercise can also cause hypoglycemia (dangerously low blood sugar) in people with diabetes during and after a workout. If...
New Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in New Studies
Positive preliminary results of an ongoing, first-in-human Phase 1/2 study demonstrating that stem cell-derived therapy can produce insulin in people with severe type 1 diabetes were published today in Cell Stem Cell and Cell Reports Medicine. “The data from these papers represent a significant scientific advance,” said Cell Reports Medicine study lead author James Shapiro, MD PhD, Canada...
In patients who have diabetes and end-stage kidney disease (ESKD), the rates of severe hypoglycemia crises requiring emergency department visits or hospitalizations are the highest so far reported, according to a nationwide study recently published in Diabetes Care. Researchers led by Rodolfo J. Galindo, MD, FACE, associate professor of medicine at Emory University School of...
COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat Cells
COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study in Cell Metabolism. Researchers led by James C. Lo, MD, PhD, an associate professor of medicine in the Weill Center for Metabolic Health and the Cardiovascular Research Institute at Weill Cornell Medicine and a cardiologist at NewYork-Presbyterian/Weill Cornell Medical Center, found that hyperglycemia is common in hospitalized COVID-19 patients and...
This week, Precision Diabetes, Inc. presented data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabetes tests in predicting mortality in hospitalized COVID-19 patients with and without diabetes. The study, “1,5-anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19,” was presented at the American Heart Association (AHA) 2021 Scientific...
